Pontine Myopericytoma: Case Report and Literature Review

Myopericytoma (MPC) is a benign soft tissue tumor that develops from perivascular myoid cells and is part of the perivascular tumor group. MPC most commonly occurs in the subcutaneous soft tissues of the extremities, while intracranial MPC is remarkably rare. Herein, we report the case of a 45-year-...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in oncology Vol. 12; p. 903655
Main Authors Guo, Maoyuan, Chen, Xue, Zhang, Gaofeng, Wang, Yongpeng
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 16.05.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Myopericytoma (MPC) is a benign soft tissue tumor that develops from perivascular myoid cells and is part of the perivascular tumor group. MPC most commonly occurs in the subcutaneous soft tissues of the extremities, while intracranial MPC is remarkably rare. Herein, we report the case of a 45-year-old woman with myopericytoma who had a 2-week history of recurrent dizziness. Magnetic resonance imaging (MRI) revealed an irregular mass in the pons, with nodular enhancement of the mass on contrast-enhanced scans. The mass was considered a vascular lesion and was highly suspected to be a hemangioblastoma, prompting surgical intervention for the patient. The postoperative pathological report corrected the initial diagnosis, hemangioblastoma, to MPC. Intracranial MPC is extremely rare and there are no detailed imaging sources for this condition; furthermore, MPC occurrence in the pons has not been reported previously. This report presents the etiological characteristics intracranial MPC as visualized through MRI data alongside a comparative discussion on other reported diagnoses that resemble MPC. The case findings will provide a more widespread understanding for radiologists regarding the differential diagnosis of intracranial blood-rich supply lesions.
Bibliography:This article was submitted to Head and Neck Cancer, a section of the journal Frontiers in Oncology
Edited by: Ignazio Gaspare Vetrano, IRCCS Carlo Besta Neurological Institute Foundation, Italy
These authors have contributed equally to this work and share first authorship
Reviewed by: Jacopo Falco, IRCCS Carlo Besta Neurological Institute Foundation, Italy; Ricardo Caramanti, Faculdade de Medicina de São José do Rio Preto, Brazil
ISSN:2234-943X
2234-943X
DOI:10.3389/fonc.2022.903655